Get the Stockscreener App
5.37
15.98%
+0.74
After Hours:
5.38
0.010
+0.19%
Essa Pharma Inc stock is currently priced at $5.37, with a 24-hour trading volume of 64,986.
It has seen a +15.98% increased in the last 24 hours and a -10.50% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $4.80 pivot point. If it approaches the $5.38 resistance level, significant changes may occur.
Previous Close:
$4.63
Open:
$4.64
24h Volume:
64,986
Market Cap:
$238.23M
Revenue:
-
Net Income/Loss:
$-25.80M
P/E Ratio:
-8.6613
EPS:
-0.62
Net Cash Flow:
$-22.19M
1W Performance:
-6.12%
1M Performance:
-10.50%
6M Performance:
-10.50%
1Y Performance:
+67.81%
1D Range:
$4.59
$5.39
52W Range:
$2.58
$11.67
Essa Pharma Inc Stock (EPIX) Company Profile
Name
Essa Pharma Inc
Sector
Industry
Phone
778-331-0962
Address
999 West Broadway, Suite 720, Vancouver, BC
Essa Pharma Inc Stock (EPIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-26-23 | Resumed | Oppenheimer | Outperform |
| Mar-04-21 | Initiated | Piper Sandler | Overweight |
| Jan-11-21 | Reiterated | H.C. Wainwright | Buy |
| Nov-02-20 | Initiated | Jefferies | Buy |
| Oct-25-19 | Initiated | Oppenheimer | Outperform |
Essa Pharma Inc Stock (EPIX) Latest News
Franklin Berger Is The Independent Director of ESSA Pharma Inc. (CVE:EPI) And They Just Picked Up 18% More Shares - Yahoo Movies UK
Yahoo Movies UK
2,298,662 Shares in ESSA Pharma Inc. (NASDAQ:EPIX) Purchased by RTW Investments LP - MarketBeat
MarketBeat
Wolverine World Wide, Inc. (NYSE:WWW) Shares Sold by BNP Paribas Financial Markets - Defense World
Defense World
Trexquant Investment LP Purchases New Holdings in Invesco KBW Bank ETF (NASDAQ:KBWB) - Defense World
Defense World
Q3 2024 EPS Estimates for ESSA Pharma Inc. Decreased by Zacks Small Cap (NASDAQ:EPIX) - MarketBeat
MarketBeat
D.A. Davidson & CO. Invests $437000 in Dollar Tree, Inc. (NASDAQ:DLTR) - Defense World
Defense World
Essa Pharma Inc Stock (EPIX) Financials Data
Essa Pharma Inc (EPIX) Net Income 2024
EPIX net income (TTM) was -$25.80 million for the quarter ending December 31, 2023, a +21.20% increase year-over-year.
Essa Pharma Inc (EPIX) Cash Flow 2024
EPIX recorded a free cash flow (TTM) of -$22.19 million for the quarter ending December 31, 2023, a +16.44% increase year-over-year.
Essa Pharma Inc (EPIX) Earnings per Share 2024
EPIX earnings per share (TTM) was -$0.59 for the quarter ending December 31, 2023, a +20.27% growth year-over-year.
About Essa Pharma Inc
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on the development of novel therapeutics for the treatment of prostate cancer. It is developing EPI-506 that is in Phase 1/2 clinical trials for the treatment of prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.
0.87%
0.21%
Cap:
|
Volume (24h):